Amedisys (AMED) Tops Q4 EPS by 1c
Get Alerts AMED Hot Sheet
EPS Growth %: +2.0%
Financial Fact:
Cost of service, excluding depreciation and amortization: 212.12M
Today's EPS Names:
CP, RUSHA, SEIC, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q4 EPS of $0.27, $0.01 better than the analyst estimate of $0.26. Revenue for the quarter came in at $300.5 million versus the consensus estimate of $301.62 million.
Paul B. Kusserow, President and Chief Executive Officer stated, "Amedisys made great strides in 2014 resulting in stabilized operations and improved financial performance while remaining focused on providing high-quality patient care. I am particularly proud of the way our employees and leadership team responded to the challenges in front of them. I am fortunate to have the opportunity to lead a great organization with such a critical mission, and I look forward to the opportunities in front of us."
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hasbro (HAS) brand strength sees earnings top expectations
- Magyar Bancorp (MGYR) Reports Q2 EPS of $0.30
- Churchill Downs (CHDN) Tops Q1 EPS by 29c
Create E-mail Alert Related Categories
Earnings, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!